PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug side effects

tadalafil Side Effects

The reactions most often reported to the FDA for tadalafil (also sold as Cialis), with demographics, serious outcomes, and reporting trends.

Data updated 2026-05-15

96,629
FAERS reports

Data from the FDA Adverse Event Reporting System (FAERS), 2004 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.

The most commonly reported side effects of tadalafil come from 96,629 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.

This page analyzes 96,629 reports to the FDA Adverse Event Reporting System (FAERS) for tadalafil (Cialis): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.

Total Reports

96,629

Reports Mentioning Death

10,913

11.3% of reports — not proof the medicine caused the death

Hospitalizations

36,455

37.7% of reports

Top Indication

Product Used For Unknown Indication

Most Reported Adverse Reactions

DYSPNOEA
11,663
HEADACHE
10,690
DIARRHOEA
7,799
NAUSEA
6,498
DEATH
5,899
FATIGUE
5,836
DIZZINESS
5,177
PNEUMONIA
4,225
COUGH
4,199
MALAISE
3,723
VOMITING
3,434
ASTHENIA
3,306
PAIN IN EXTREMITY
3,297
PAIN
3,291
FLUID RETENTION
3,149
HYPOTENSION
2,970
PULMONARY ARTERIAL HYPERTENSION
2,840
FLUSHING
2,767

Who Reports Side Effects

Gender Distribution

Female 48,958 (53%)
Male 43,694 (47%)
Unknown 52

Age Distribution

0-17 2,493 (4%)
18-44 10,011 (16%)
45-64 25,717 (40%)
65-74 15,808 (24%)
75+ 10,533 (16%)

Reporting Trend by Year

2004 2025

Reactions in Death Reports

Top reactions reported in 10,913 reports where death was an outcome. These are voluntarily reported and do not establish causation.

Reaction Reports
DEATH 5,856
DYSPNOEA 1,277
PULMONARY ARTERIAL HYPERTENSION 1,043
DIARRHOEA 630
PNEUMONIA 622
PULMONARY HYPERTENSION 554
HEADACHE 547
CARDIAC FAILURE 516
RIGHT VENTRICULAR FAILURE 470
NAUSEA 458
RESPIRATORY FAILURE 436
FLUID RETENTION 407
HYPOTENSION 407
DISEASE PROGRESSION 383
CONDITION AGGRAVATED 380
FATIGUE 376
MALAISE 350
CARDIAC ARREST 345
FALL 281

Reactions in Hospitalization Reports

Top reactions in 36,455 reports where hospitalization was an outcome.

Reaction Reports
DYSPNOEA 6,932
PNEUMONIA 3,625
HEADACHE 3,525
DIARRHOEA 3,413
NAUSEA 2,867
FLUID RETENTION 2,396
FATIGUE 2,191
PULMONARY ARTERIAL HYPERTENSION 1,970
DIZZINESS 1,968
VOMITING 1,919
MALAISE 1,887
HYPOTENSION 1,796
DEATH 1,725
CHEST PAIN 1,634
COUGH 1,534
FALL 1,518
HOSPITALISATION 1,478
ASTHENIA 1,385
OXYGEN SATURATION DECREASED 1,375
PYREXIA 1,367

Compare tadalafil vs alfuzosin →

What the FAERS Data Reveals About tadalafil Side Effects

The FDA Adverse Event Reporting System (FAERS) contains 96,629 voluntary reports linked to tadalafil and its brand equivalents (Cialis), spanning 2004 through 2025. Of those, 10,913 (11.3%) listed death as an outcome and 36,455 (37.7%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.

Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 53% were female and 47% male; age distribution skews toward 45-64, with 25,717 reports in that bracket. The single most reported reaction is dyspnoea with 11,663 submissions, followed by headache and diarrhoea.

How to read these numbers

FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.